MD Magazine: Condition Center: Oncology Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/conditions/oncology/rss Oncology en-us Mon, 23 Sep 2019 18:38:24 +0000 FDA Finds Carcinogen in Zantac http://www.mdmag.com/medical-news/fda-finds-carcinogen-zantac http://www.mdmag.com/medical-news/fda-finds-carcinogen-zantac Fri, 13 Sep 2019 17:11:00 +0000 ESC Provides New Acute Pulmonary Embolism Guideline http://www.mdmag.com/medical-news/esc-acute-pulmonary-embolism-guideline http://www.mdmag.com/medical-news/esc-acute-pulmonary-embolism-guideline Sat, 31 Aug 2019 13:00:00 +0000 FDA Approves Fedratinib for Forms of Myelofibrosis http://www.mdmag.com/medical-news/fda-approves-fedratinib-for-forms-of-myelofibrosis http://www.mdmag.com/medical-news/fda-approves-fedratinib-for-forms-of-myelofibrosis Fri, 16 Aug 2019 14:52:00 +0000 DocTalk Tweet Chat "The State of Liver Disease" Scheduled for August 14 http://www.mdmag.com/medical-news/doctalk-tweet-chat-liver-disease-august-14 http://www.mdmag.com/medical-news/doctalk-tweet-chat-liver-disease-august-14 Mon, 12 Aug 2019 16:45:00 +0000 Annual Medical Aid in Dying Requests Consistent in Oregon, Washington http://www.mdmag.com/medical-news/annual-medical-aid-in-dying-requests-oregon-washington http://www.mdmag.com/medical-news/annual-medical-aid-in-dying-requests-oregon-washington Fri, 09 Aug 2019 15:00:00 +0000 FDA Approves Pexidartinib as First TGCT Therapy http://www.mdmag.com/medical-news/fda-pexidartinib-first-tgct-therapy http://www.mdmag.com/medical-news/fda-pexidartinib-first-tgct-therapy Fri, 02 Aug 2019 20:06:00 +0000 Biden Cancer Initiative Suspended During Campaign http://www.mdmag.com/medical-news/biden-cancer-initiative-suspended-during-campaign http://www.mdmag.com/medical-news/biden-cancer-initiative-suspended-during-campaign Tue, 16 Jul 2019 19:47:00 +0000 FDA Approves Daratumumab as Combination Multiple Myeloma Drug http://www.mdmag.com/medical-news/fda-daratumumab-combination-multiple-myeloma http://www.mdmag.com/medical-news/fda-daratumumab-combination-multiple-myeloma Thu, 27 Jun 2019 19:05:00 +0000 Ruben Mesa, MD: Ruxolitinib as a Myelofibrosis Treatment http://www.mdmag.com/conference-coverage/asco-2019/ruben-mesa-md-ruxolitinib-as-a-myelofibrosis-treatment http://www.mdmag.com/conference-coverage/asco-2019/ruben-mesa-md-ruxolitinib-as-a-myelofibrosis-treatment Fri, 07 Jun 2019 13:26:00 +0000 Ruben Mesa, MD: Myelofibrosis Patients Frequently Present Symptoms http://www.mdmag.com/conference-coverage/asco-2019/ruben-mesa-md-myelofibrosis-patients-frequently-present-symptoms http://www.mdmag.com/conference-coverage/asco-2019/ruben-mesa-md-myelofibrosis-patients-frequently-present-symptoms Fri, 07 Jun 2019 09:00:00 +0000 Naveen Pemmaraju, MD: Tagraxofusp for BPDCN http://www.mdmag.com/conference-coverage/asco-2019/naveen-pemmaraju-md-tagraxofusp-for-bpdcn http://www.mdmag.com/conference-coverage/asco-2019/naveen-pemmaraju-md-tagraxofusp-for-bpdcn Thu, 06 Jun 2019 15:18:00 +0000 Naveen Pemmaraju, MD: Managing Anemia with Ruxolitinib Care http://www.mdmag.com/conference-coverage/asco-2019/naveen-pammaraju-md-managing-anemia-with-ruxolitinib-care http://www.mdmag.com/conference-coverage/asco-2019/naveen-pammaraju-md-managing-anemia-with-ruxolitinib-care Wed, 05 Jun 2019 13:17:00 +0000 New Therapy on Horizon for Rare Lung Cancer Subtype http://www.mdmag.com/conference-coverage/asco-2019/new-therapy-on-horizon-for-rare-lung-cancer-subtype http://www.mdmag.com/conference-coverage/asco-2019/new-therapy-on-horizon-for-rare-lung-cancer-subtype Tue, 04 Jun 2019 18:11:00 +0000 Naveen Pammaraju, MD: Primary Care & JAK1 Inhibitors in Myelofibrosis http://www.mdmag.com/conference-coverage/asco-2019/naveen-pammaraju-primary-care-jak1-inhibitors-myelofibrosis http://www.mdmag.com/conference-coverage/asco-2019/naveen-pammaraju-primary-care-jak1-inhibitors-myelofibrosis Tue, 04 Jun 2019 13:41:00 +0000 Investigational Isatuximab Shows Added Benefit for Multiple Myeloma http://www.mdmag.com/conference-coverage/asco-2019/investigational-isatuximab-benefit-multiple-myeloma http://www.mdmag.com/conference-coverage/asco-2019/investigational-isatuximab-benefit-multiple-myeloma Mon, 03 Jun 2019 19:53:00 +0000 New Immunotherapy Blocks Key Macrophage Checkpoint in AML Care http://www.mdmag.com/conference-coverage/asco-2019/new-immunotherapy-key-macrophage-aml-care http://www.mdmag.com/conference-coverage/asco-2019/new-immunotherapy-key-macrophage-aml-care Mon, 03 Jun 2019 19:10:00 +0000 Subcutaneous Daratumumab Non-Inferior, Less Burdensome than IV Regimen http://www.mdmag.com/conference-coverage/asco-2019/subcutaneous-daratumumab-non-inferior-less-burdensome-iv http://www.mdmag.com/conference-coverage/asco-2019/subcutaneous-daratumumab-non-inferior-less-burdensome-iv Mon, 03 Jun 2019 12:29:00 +0000 Primary Care Physicians Hold Significant Value in Oncology Care http://www.mdmag.com/conference-coverage/asco-2019/primary-care-physicians-value-oncology http://www.mdmag.com/conference-coverage/asco-2019/primary-care-physicians-value-oncology Mon, 03 Jun 2019 11:45:00 +0000 Low-Income, Female Patients Likely to Face Delayed Leukemia Diagnoses http://www.mdmag.com/conference-coverage/asco-2019/low-income-female-patients-delayed-leukemia-diagnoses http://www.mdmag.com/conference-coverage/asco-2019/low-income-female-patients-delayed-leukemia-diagnoses Sun, 02 Jun 2019 15:02:00 +0000 Adenoid Cystic Carcinoma Does Not Vary According to Race, Gender http://www.mdmag.com/conference-coverage/asco-2019/adenoid-cystic-carcinoma-doesnt-vary-according-to-race-gender http://www.mdmag.com/conference-coverage/asco-2019/adenoid-cystic-carcinoma-doesnt-vary-according-to-race-gender Sat, 01 Jun 2019 11:00:00 +0000 Rituximab Infusion Side Effects Abated by Rupatadine, Montelukast http://www.mdmag.com/conference-coverage/asco-2019/rituximab-infusion-side-effects-rupatadine-montelukast http://www.mdmag.com/conference-coverage/asco-2019/rituximab-infusion-side-effects-rupatadine-montelukast Sat, 01 Jun 2019 09:00:00 +0000 VIT Improves Survival Measures in Patients with Relapsed/Refractory RMS http://www.mdmag.com/conference-coverage/asco-2019/vit-survival-patients-relapsed-refractory-rms http://www.mdmag.com/conference-coverage/asco-2019/vit-survival-patients-relapsed-refractory-rms Fri, 31 May 2019 11:00:00 +0000 Donald Tashkin, MD: Advancing Marijuana Lung Health Trials http://www.mdmag.com/conference-coverage/ats-2019/donald-tashkin-md-advancing-marijuana-lung-health-trials http://www.mdmag.com/conference-coverage/ats-2019/donald-tashkin-md-advancing-marijuana-lung-health-trials Mon, 20 May 2019 14:10:00 +0000 Cancer Patients with Treated HCV Suitable for Chemo Trials http://www.mdmag.com/medical-news/cancer-patients-treated-hcv-suitable-chemo-trials http://www.mdmag.com/medical-news/cancer-patients-treated-hcv-suitable-chemo-trials Wed, 27 Mar 2019 09:00:00 +0000 FDA Designates PRM-151 Breakthrough Therapy for Idiopathic Pulmonary Fibrosis http://www.mdmag.com/medical-news/fda-prm151-breakthrough-therapy-idiopathic-pulmonary-fibrosis http://www.mdmag.com/medical-news/fda-prm151-breakthrough-therapy-idiopathic-pulmonary-fibrosis Tue, 26 Mar 2019 14:03:00 +0000 Targeting an Immune Regulating Protein May Help Halt Glioblastoma Progression http://www.mdmag.com/medical-news/targeting-immune-regulating-protein-may-help-halt-glioblastoma-progression http://www.mdmag.com/medical-news/targeting-immune-regulating-protein-may-help-halt-glioblastoma-progression Fri, 08 Feb 2019 15:35:00 +0000 Engineered Cancer Antivirus Has Antisarcoma Effect http://www.mdmag.com/medical-news/engineered-cancer-antivirus-antisarcoma-effect http://www.mdmag.com/medical-news/engineered-cancer-antivirus-antisarcoma-effect Mon, 04 Feb 2019 14:45:00 +0000 Therapeutic Target for Medulloblastoma Identified in Mice Models http://www.mdmag.com/medical-news/therapeutic-target-medulloblastoma-identified-mice-models http://www.mdmag.com/medical-news/therapeutic-target-medulloblastoma-identified-mice-models Tue, 29 Jan 2019 14:46:00 +0000 FDA Approves Ibrutinib/Obinutuzumab for Treatment-Naive Patients with Chronic Lymphocytic Leukemia http://www.mdmag.com/medical-news/fda-approves-ibrutinibobinutuzumab-treatmentnaive-patients-chronic-lymphocytic-leukemia http://www.mdmag.com/medical-news/fda-approves-ibrutinibobinutuzumab-treatmentnaive-patients-chronic-lymphocytic-leukemia Mon, 28 Jan 2019 17:00:00 +0000 Refining Leukemia Classification for More Accurate Diagnoses http://www.mdmag.com/medical-news/refining-leukemia-classification-more-accurate-diagnoses http://www.mdmag.com/medical-news/refining-leukemia-classification-more-accurate-diagnoses Wed, 23 Jan 2019 16:30:00 +0000